Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Opioid Safety”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01838616
What this trial is testing

Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.

Who this might be right for
Back PainLow Back PainNeuropathic Pain
Grünenthal GmbH 367
Not applicableStudy completedNCT03769428
What this trial is testing

Postoperative Analgesia in Breast Cancer Surgery: Safety and Efficiency of Ultrasound Guided Erector Spinae Plane Block

Who this might be right for
Breast Cancer SurgeryPostoperative Analgesia
Ben marzouk Sofiene 60
Large-scale testing (Phase 3)Study completedNCT00271466
What this trial is testing

Assess the Safety, Dose Conversion, and Dose Individualization of Duragesic® (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Narcotic Pain Relief Therapy

Who this might be right for
Chronic Pain
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 199
Large-scale testing (Phase 3)Study completedNCT00015171
What this trial is testing

Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1

Who this might be right for
Heroin DependenceSubstance-Related Disorders
National Institute on Drug Abuse (NIDA)
Large-scale testing (Phase 3)Study completedNCT00348452
What this trial is testing

A Study Comparing the Effectiveness and Safety of Extended Release Tramadol HCl at 100 mg, 200 mg and 300 mg Doses to Placebo for the Treatment of Moderate to Severe Pain Due to Osteoarthritis (OA)

Who this might be right for
Chronic Pain
Bausch Health Americas, Inc. 1,000
Large-scale testing (Phase 3)Study completedNCT00410748
What this trial is testing

Safety and Tolerability of Long-Term Administration of Hydromorphone HCI CR (Controlled Release)

Who this might be right for
PainAnalgesics, Opioid
Alza Corporation, DE, USA 388
Early research (Phase 1)Ended earlyNCT00783172
What this trial is testing

Opioid Growth Factor (OGF) and Gemcitabine: Novel Treatment for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Milton S. Hershey Medical Center 4
Large-scale testing (Phase 3)Study completedNCT01452529
What this trial is testing

Efficacy and Safety of Hydrocodone Bitartrate (HYD) in Subjects With Moderate to Severe Chronic Low Back Pain

Who this might be right for
Chronic Low Back Pain
Purdue Pharma LP 905
Large-scale testing (Phase 3)Study completedNCT00468845
What this trial is testing

Study Of The Efficacy And Safety Of Pregabalin Compared To Placebo For Treatment Of Post-Surgical Pain From Hysterectomy

Who this might be right for
Pain, Postoperative
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 501
Testing effectiveness (Phase 2)Study completedNCT01040637
What this trial is testing

A Multiple Dose Study of TD-1211 in Healthy Volunteers and Patients With Opioid-Induced Constipation

Who this might be right for
HealthyOpioid-induced Constipation
Glycyx Therapeutics 102
Testing effectiveness (Phase 2)Ended earlyNCT00351637
What this trial is testing

Sublingual Methadone for the Management of Cancer-related Procedure Pain in Inpatients

Who this might be right for
CancerPain
Alberta Health services 60
Large-scale testing (Phase 3)Study completedNCT00315887
What this trial is testing

The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Chronic Back Pain.

Who this might be right for
Chronic Low Back Pain
Purdue Pharma LP 250
Early research (Phase 1)Study completedNCT04447287
What this trial is testing

Assess the Effect of a Single Dose of ASP8062 on the Multiple Dose Safety, Tolerability and Pharmacokinetics of Buprenorphine/Naloxone in Participants With Opioid Use Disorder

Who this might be right for
Opioid Use Disorder
Astellas Pharma Global Development, Inc. 23
Not applicableStudy completedNCT03685162
What this trial is testing

Observational Study to Evaluate Levomethadone Safety and Effectiveness in Subjects Under Opioid Maintenance Treatment

Who this might be right for
Opioid Addiction
L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A. 103
Early research (Phase 1)Ended earlyNCT01431586
What this trial is testing

First in Humans Study of JDTic

Who this might be right for
Cocaine Dependence
RTI International 24
Large-scale testing (Phase 3)Study completedNCT01309386
What this trial is testing

A Safety and Efficacy Study of Oral Tapentadol Extended-Release in Japanese Participants

Who this might be right for
Neoplasms
Janssen Pharmaceutical K.K. 100
Early research (Phase 1)Study completedNCT04828694
What this trial is testing

Pharmacokinetic and Safety Study of Naltrexone Release From Subcutaneous BICX104 Pellets Compared to Vivitrol Injections

Who this might be right for
Opioid-use Disorder
BioCorRx Inc 24
Early research (Phase 1)Study completedNCT02576353
What this trial is testing

Fentanyl Sublingual Spray and Fentanyl Citrate Intravenous (IV) in Opioid Naive Subjects

Who this might be right for
Pharmacokinetics and Pharmacodynamics
INSYS Therapeutics Inc 50
Testing effectiveness (Phase 2)Study completedNCT00135577
What this trial is testing

Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects

Who this might be right for
CancerBowel Dysfunction
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 67
Testing effectiveness (Phase 2)Study completedNCT06576843
What this trial is testing

INDV-6001 Multiple-Dose Pharmacokinetic Study

Who this might be right for
Moderate to Severe Opioid Use Disorder
Indivior Inc. 123
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation